Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medicxi

Medicxi
VC INVESTOR TYPE
Active STATUS
13 PROFESSIONALS
35 INVESTMENTS
29 PORTFOLIO
5 EXITS
Description

Medicxi is a life sciences-focused venture capital investment firm that is headquartered in London, United Kingdom with additional offices in Geneva, Switzerland and Saint Helier, United Kingdom. The firm prefers to invest in the healthcare, academia, biotech and pharmaceutical sectors and was founded in 2016.

Website
Formerly Known As
Index Ventures Life Sciences
Investor Status
Actively Seeking New Investments
Year Founded
2016
Primary Investor Type
Venture Capital
Primary Office
  • 25 Great Pulteney Street
  • London W1F 9LT
  • England, United Kingdom

+44 020 0000 0000

Medicxi Investments (35)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Divide & Conquer 18-Sep-2019 Early Stage VC 000.00 Biotechnology Startup
0000000000 0000000 08-Jul-2019 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 000 0000000 00.0
0000000 0000000000 15-May-2019 00 000000000 00000 Biotechnology Clinical Trials - Phase 3 000 0000000 00.0
00000000 000000000 08-Apr-2019 00000 00000 0000 Biotechnology Pre-Clinical Trials 0000è00 000000 00
0000 00000000000 02-Apr-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 1 00000000 0000000 00.0
0000000000 000 29-Mar-2019 00000 00000 000.00 Drug Discovery Stealth 0000è00 000000 00
00000 000000000000 15-Mar-2019 00000 00000 00.000 Drug Discovery Startup
000000 06-Feb-2019 00000 00000 00.000 Pharmaceuticals Startup 000000000 00 00000000 00.0
Inexia 04-Feb-2019 Early Stage VC 00.000 Pharmaceuticals Generating Revenue 000000000 00 00000000 00.0
Morphogen-IX 18-Dec-2018 Early Stage VC 0000 Drug Discovery Product Development 00000 00000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Medicxi’s full profile, request a free trial.

Medicxi Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
Synthorx 07-Dec-2018 IPO 00000 Completed
000000 00000000000 07-Jan-2018 000000000000000000 000 Completed
  • 0000000
Cosmo Pharmaceuticals 31-Mar-2017 Public Investment 2nd Offering 00000 Completed
Aravive Inc 21-Mar-2014 IPO 00000 Completed
To view this investor’s complete exits history, request access »

Medicxi Team (22)

Name Title Deals Funds Boards Office Contact
Info
Francesco De Rubertis Ph.D Co-Founder & Partner 0 0 0 Geneva, Switzerland
Giuseppe Zocco Co-Founder & Partner 00 0 Geneva, Switzerland
Kevin Johnson Ph.D Co-Founder & Partner 00 0 00 London, United Kingdom
Michèle Ollier MD Co-Founder & Partner 00 0 00 Geneva, Switzerland
David Grainger Ph.D Co-Founder, Partner and Chief Scientific Advisor 00 0 00 London, United Kingdom

5 Former Team Members

You’re viewing 5 of 22 team members. Get the full list »